CA protects against endothelial dysfunction and oxidative stress in diabetes and obesity by targeting PPARδ through Nrf2/HO-1 and Akt/eNOS signaling pathways. This evidence concerns the gene NOS3 and obesity due to melanocortin 4 receptor deficiency.